Prior to representing the great people of East Tennessee in Congress, I served for 30+ years as a licensed community pharmacist. Healthcare issues and solving patient problems are near and dear to me.
As a member of the House Republican Doctors Caucus, I understand the importance of reducing health care costs and increasing access to care. And I know how Obamacare has wreaked havoc on our healthcare system, driving up costs, making the system more complex and confusing, and empowering bureaucrats and insurance companies over patients. Our current healthcare system is deeply flawed, forcing folks into insurance plans that don’t fit their needs and away from doctors they trust.
Unlike the government-run overreach of Obamacare, I believe in personalized medicine as part of a reformed and modernized healthcare system, one where patients and healthcare providers have more ownership and control over their own healthcare dollars and decisions. This sort of modernized healthcare system should include:
- Common-sense patient protections
- Competition and consumer choices
- Price and quality transparency
- Reducing our reliance on China and other adversary countries
- Addressing health professional workforce shortages
- Rooting out waste, fraud and abuse
- Incentives to lower or restrain costs while improving quality, access and innovation
Guided by these principles, as a member of the House Committee on Energy & Commerce I am taking an active role in developing and supporting meaningful legislation and policies that will make a difference for individuals, families, patients and providers in East Tennessee.
More on Health Care
WASHINGTON, D.C. — This week, Congresswoman Diana Harshbarger (R-TN), Co-Chair of the Congressional Bipartisan Rural Health Caucus, delivered remarks on the House Floor celebrating National Rural Health Month and reaffirming her commitment to strengthening healthcare access in America’s small towns and rural communities.
Thursday, November 6, 2025 – The U.S. Food and Drug Administration (FDA) recently announced that it will provide USAntibiotics — located in Bristol, Tennessee — a National Priority Voucher for the company’s Augmentin XR (Amoxicillin Clavulanic Potassium) product. This medication treats community-acquired pneumonia and acute bacterial sinusitis caused by penicillin-resistant bacteria.
Washington, D.C. — Congresswoman Diana Harshbarger (TN-01) today celebrated the launch of the $50 Billion Rural Health Transformation (RHT) Fund by HHS Secretary Robert F. Kennedy, Jr. and CMS Administrator Dr. Mehmet Oz, officially opening the state application process. The RHT fund was created in President Trump’s Working Families Tax Cuts legislation that Congresswoman Harshbarger supported.
Washington, D.C. — Congresswoman Diana Harshbarger (R-TN) and Congressman Buddy Carter (R-GA), the only two pharmacists serving in the U.S. House of Representatives, this week introduced the Drug Shortage Compounding Patient Access Act of 2025 (H.R. 5316). The legislation strengthens patient access to essential medications during times of shortage and reduces dependence on foreign drug suppliers by ensuring compounding pharmacies can continue filling critical gaps in care.
WASHINGTON, D.C. — Congresswoman Diana Harshbarger (TN-01) today congratulated USAntibiotics, McKesson, and Walmart on a new collaboration that will expand U.S.-based production and distribution of amoxicillin, one of the nation’s most widely prescribed antibiotics. The effort is anchored at USAntibiotics’ world-class manufacturing facility in Bristol, Tennessee and is designed to ensure stable, domestically produced supplies for patients nationwide.
Washington, D.C. — Congresswoman Diana Harshbarger, Pharm.D. (R-TN), along with GOP Doctors Caucus co-chair Congressman Greg Murphy, M.D. (R-NC), led a coalition of Republican physicians and medical professionals in Congress in calling for a complete overhaul of the U.S. Preventive Services Task Force (USPSTF), which they say has strayed from its mission of saving lives through evidence-based preventive care and instead drifted into divisive political territory.
|
Representatives Diana Harshbarger and Juan Vargas (CA-52) introduced the United States-Abraham Accords Cooperation and Security Act, bipartisan legislation that will establish a U.S. Food and Drug Administration Abraham Accords bureau to provide guidance and technical assistance aimed at protecting our medical supply chains and ending our reliance on adversarial nations like China.
More than 80% of the Active Pharmaceutical Ingredients for drugs sold in the U.S. are imported from foreign countries, primarily India and China.
WASHINGTON, D.C. - Yesterday, Representatives Diana Harshbarger (TN-01) and Juan Vargas (CA-52) introduced the United States-Abraham Accords Cooperation and Security Act, bipartisan legislation that will establish a U.S. Food and Drug Administration (FDA) Abraham Accords bureau to provide guidance and technical assistance aimed at protecting our medical supply chains and ending our reliance on adversarial nations like China.
Republican Tennessee Rep. Diana Harshbarger and Democratic California Rep. Juan Vargas will introduce legislation Wednesday that would establish a U.S. Food & Drug Administration (FDA) Abraham Accords bureau to protect U.S. pharmaceutical supply chains and end reliance on countries like China.
The Daily Caller first obtained a copy of the legislation, which is titled The United States-Abraham Accords Cooperation and Security Act. The bill would specifically task the Abraham Accords FDA bureau to do the following, according to Harshbarger’s office: